Skip to content
In English |
En español
Search
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate
Denosumab May Help Prevent Bone Loss
Past Highlights
Results:
1 -4 of 4
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
Last Modified:
7/11/2007
 
First Published:
4/1/2001
1.
Phase III Randomized Study of Aerosolized Ribavirin With or Without Palivizumab in Patients With Respiratory Syncytial Virus Pneumonia Following Stem Cell Transplantation
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Supportive care
Closed
Any age
NCI
FHCRC-1379.00
NCI-G01-1929, NCT00014391
Last Modified:
11/1/2006
 
First Published:
5/1/2001
2.
Phase III Randomized Study of Aerosolized Ribavirin Versus Standard Supportive Therapy in Patients With Respiratory Syncytial Virus Following Stem Cell Transplantation
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Supportive care
Closed
2 and over
NCI
FHCRC-1290.00
NCI-G01-1939, NCT00016081
Last Modified:
10/1/1993
3.
Phase II Pilot Study of Induction Therapy with Tiazofurin Followed by Maintenance Therapy with Ribavirin in Patients with Nonlymphoid Blast Crisis of Chronic Myelogenous Leukemia (Summary Last Modified 10/93)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
15 and over
NCI
UARK-92016
NCI-T92-0173O, T92-0173
Last Modified:
9/11/2008
 
First Published:
5/29/2008
4.
Study of the Effects of Immune-Modulating Therapies on Tissue Expression of Indoleamine 2, 3 dioxygenase in Patients With Untreated Acute or Chronic Hepatitis C, Metastatic Melanoma, or Crohn Disease
Phase
Type
Status
Age
Sponsor
Protocol IDs
No phase specified
Biomarker/Laboratory analysis
Completed
No age specified
NCI
VU-VICC-MEL-0651
VICC-MEL-0651, VU-VICC-060614
Select All on One Page
NCI Home
|
Text-Only Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute